SMMT
Summit Therapeutics Inc Earnings
$19.89
Earnings Summary
Revenue | $0Mn |
Net Profits | $-61.2Mn |
Net Profit Margins | -Inf% |
Summit Therapeutics Inc’s revenue jumped NaN% since last year same period to $0Mn in the Q4 2024. On a quarterly growth basis, Summit Therapeutics Inc has generated NaN% jump in its revenue since last 3-months.
Summit Therapeutics Inc’s net profit fell -187.77% since last year same period to $-61.2Mn in the Q4 2024. On a quarterly growth basis, Summit Therapeutics Inc has generated -8.8% fall in its net profits since last 3-months.
Summit Therapeutics Inc’s net profit margin jumped NaN% since last year same period to -Inf% in the Q4 2024. On a quarterly growth basis, Summit Therapeutics Inc has generated NaN% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | -0.06 |
EPS Estimate Current Year | -0.06 |
Summit Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at -0.06 - a -2.17% fall from last quarter’s estimates.
Summit Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at -0.06.
Key Ratios
Earning Per Share (EPS) | -0.06 |
Summit Therapeutics Inc’s earning per share (EPS) fell -111% since last year same period to -0.06 in the Q4 2024. This indicates that the Summit Therapeutics Inc has generated -111% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2025-02-24 | -0.06 | -0.06 | -3.26% |
2024-08-06 | -0.06 | -0.09 | -50% |
2024-05-01 | -0.06 | -0.06 | 0% |
